MedTrace Logo

Risk of Acute Kidney Injury in Living Liver Donor Surgery

NCT05255510 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2022-05-12

No results posted yet for this study

Summary

Acute kidney injury (AKI) is one of the most common complication after restricted fluid therapy for major surgery. The aim of this study is to evaluate the incidence of AKI as defined by Kidney Disease Improving Global Outcomes (KDIGO) criteria in living liver donor hepatectomy in which applied intraoperative protocolized fluid restriction targeting a low central venous pressure (CVP) level and high pulse pressure variation (PPV) / systolic pressure variation (SPV).

Conditions

Sponsors & Collaborators

  • Elvan Onur Kırımker

    collaborator UNKNOWN

  • Sevcan Büyük

    collaborator UNKNOWN

  • Elif Beyza Baskan

    collaborator UNKNOWN

  • Ali Abbas Yılmaz

    collaborator UNKNOWN

  • Deniz Balcı

    collaborator UNKNOWN

  • Kaan Karayalçın

    collaborator UNKNOWN

  • Mustafa Kemal Bayar

    collaborator UNKNOWN

  • Ankara University

    lead OTHER

Principal Investigators

  • Süheyla Karadağ Erkoç · Ankara University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-10
Primary Completion
2020-06-01
Completion
2021-06-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05255510 on ClinicalTrials.gov